investorscraft@gmail.com

Intrinsic ValueIvy Cosmetics Corporation (4918.T)

Previous Close¥371.00
Intrinsic Value
Upside potential
Previous Close
¥371.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ivy Cosmetics Corporation operates in the competitive Japanese household and personal products sector, specializing in cosmetics and beauty supplements. The company’s diversified product portfolio includes penetrating beauty liquids, lotions, creams, and cleansing products, alongside optional care, makeup, hair care, and men’s cosmetics. Ivy Cosmetics also extends into health foods and UV protection, leveraging a multi-category approach to capture consumer demand across beauty and wellness segments. Positioned as a niche player, the company focuses on domestic markets, with its headquarters in Tokyo reinforcing its local presence. While not a market leader, Ivy Cosmetics maintains steady demand through its broad product range and established brand identity, formerly known as Shirogane Corporation. The company’s strategy emphasizes product diversification and accessibility, though it faces stiff competition from larger global and regional beauty brands. Its ability to sustain profitability in a saturated market hinges on operational efficiency and targeted product innovation.

Revenue Profitability And Efficiency

For FY 2024, Ivy Cosmetics reported revenue of JPY 2.71 billion, with net income of JPY 160.3 million, reflecting modest profitability in a competitive landscape. The diluted EPS of JPY 32.16 indicates reasonable earnings distribution relative to its market cap. Operating cash flow stood at JPY 453.1 million, suggesting healthy cash generation, though capital expenditures were limited at JPY -44.4 million, reflecting cautious reinvestment.

Earnings Power And Capital Efficiency

The company’s earnings power appears stable, supported by consistent revenue streams from its beauty and supplement lines. With an operating cash flow significantly higher than net income, Ivy Cosmetics demonstrates efficient working capital management. However, its capital efficiency is tempered by limited reinvestment, as seen in low capex, which may constrain long-term growth without strategic expansion.

Balance Sheet And Financial Health

Ivy Cosmetics maintains a conservative balance sheet, with JPY 208.7 million in cash and equivalents against total debt of JPY 451.7 million. The debt level is manageable given its cash flow, but the modest cash reserve suggests limited liquidity buffers. The absence of aggressive leverage indicates a focus on financial stability, though it may limit scalability in the near term.

Growth Trends And Dividend Policy

Growth trends appear muted, with revenue and net income reflecting steady but unspectacular performance. The company’s dividend payout of JPY 30 per share signals a commitment to shareholder returns, though yield sustainability depends on maintaining current profitability. Given the competitive industry, Ivy Cosmetics may prioritize stability over aggressive expansion.

Valuation And Market Expectations

With a market cap of JPY 1.77 billion and a beta of 0.066, Ivy Cosmetics is viewed as a low-volatility defensive stock. The valuation aligns with its modest earnings and sector positioning, though investor expectations remain tempered due to limited growth catalysts and a saturated market.

Strategic Advantages And Outlook

Ivy Cosmetics’ strategic advantage lies in its diversified product range and established domestic presence. However, the outlook remains cautious, as the company must navigate intense competition and potential margin pressures. Future success may depend on product innovation or strategic partnerships to enhance market penetration beyond its current niche.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount